PHARMACEUTICAL COMPOSITION COMPRISING RED GINSENG ACID POLYSACCHARIDE FOR TREATING HYPERLIPIDEMIA

摘要

A composition comprising red ginseng acid polysaccharide(RGAP) is provided to decrease the concentrations of triglyceride(TG) and cholesterol selectively by distinguishing symptoms of endogenous hyperlipidemia and exogenous hyperlipidemia, thereby being effectively used for preventing and treating hyperlipidemia. A pharmaceutical composition for preventing and treating hyperlipidemia comprises RGAP, which is isolated from red ginseng, includes 41.6-60.0 mol.% of glucuronic acid, 2.5-7.5 mol.% of galacturonic acid, 18.8-33.4 mol.% of glucose and 1.1-2.1 mol.% of arabinose and is an acid polysaccharide having a molecular weight of 12,000-450,000.